A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer

Summary

This study is divided into two stages: dose escalation and dose extension, including a single dose and a multiple dose clinical study. This is a single-center, open, non randomized, single arm study to the safety and tolerability of TQB3015 tables in patients with advanced malignant cancer.

Timeline

Start

2023-12

Primary completion

2024-05

Completion

2024-05

Outcome

Outcome not reported

Stopped: “The sponsor voluntarily withdraw the project.”

Drugs

Indications